Research and innovation news

An international team of scientists and doctors has identified a family of five new genetic diseases which are likely to affect more than 1 in 5000 children.

We'd like to say a massive thank you to everyone who participated in, delivered or supported research at Manchester University NHS Foundation Trust during 2017. 

At the start of 2017 teams were challenged to pursue as many first patients recruited to commercially sponsored trials as they could, whether first global, European or UK. Find out how well they did!

The World Health Organization (WHO) is recommending early use of tranexamic acid to treat bleeding post childbirth after fresh analysis of the WOMAN trial was published in The Lancet.

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human. It successfully lowered the level of the harmful huntingtin protein the nervous system.

An international team of scientists and doctors has identified a new disease that results in low levels of a common protein found inside our cells.

This international study will compare the device settings in around 2000 people living with an irregular heart rhythm

Manchester CRF, the UK’s largest Clinical Research Facility, has been strengthened by the election of Mark Samuels to the Governance Board.